Polymer nanomedicines (macromolecular therapeutics, polymer-drug conjugates, drug-free
macromolecular therapeutics) are a group of biologically active compounds that are …

Various polymers have been tested for protein conjugation with a goal of bridging the
complementary advantages of both components. However, many of these polymers …

Polymer-drug conjugates has significantly improved the anti-tumor efficacy of
chemotherapeutic drugs and alleviated their side effects. N-(1, 3-dihydroxypropan-2-yl) …

In this study, we designed and fabricated a novel amphiphilic biodegradable triblock N-(2-
hydroxypropyl methyl) acrylamide (HPMA) copolymer-gadolinium-paclitaxel-Cyanine5. 5 …

Biocompatible, stimuli-responsive, intelligent and efficient drug delivery systems are
essential for effectively suppressing cancer and reducing toxic side effects of …

This work presents a new method for the synthesis of antifouling polymer brushes using
surface-initiated photoinduced electron transfer-reversible addition–fragmentation chain …

To avoid poly (ethylene glycol)-related issues of nanomedicines such as accelerated blood
clearance, fully N-2-hydroxypropyl methacrylamide (HPMAm)-based polymeric micelles …

Owing to their dendritic architectural features, branched copolymers have been investigated
as drug delivery systems. In this paper, an enzyme-and pH-sensitive branched poly [N-(2 …

Recently, numerous polymer materials have been employed as drug carrier systems in
medicinal research, and their detailed properties have been thoroughly evaluated. Water …

It is almost four decades since N-(2-hydroxypropyl) methacrylamide (HPMA)-based
copolymers arose as drug carriers. Although fundamentals have been established and …